Related Experiment Video
Updated: Mar 29, 2026
Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
Published on: September 9, 2020
[Orthopedic Management of Skeletal Metastases]
Nokitaka Setsu1, Eisuke Kobayashi, Akira Kawai
1Division of Musculoskeletal Oncology, National Cancer Center Hospital.
Abstract:
Recent advances in drug therapy for metastatic bone diseases are changing the indications for surgical treatments. Bone modifying agents, including bisphosphonates and denosumab, have reduced skeletal-related events. Meanwhile, novel anticancer drugs that have been developed, especially molecular-targeted drugs, can improve the prognoses of patients with bone metastases, thereby potentially increasing the number of patients who could receive benefits from surgeries for metastases. A multidisciplinary approach and the early involvement of surgeons are required for the application of adequate orthopedic treatments, including braces, rehabilitation, and surgeries for local tumor control, palliative fixation, and spinal decompression.
Insights
Advances in drug therapies for bone metastases are altering surgical treatment indications. Bone modifying agents and novel anticancer drugs improve patient prognoses, increasing surgical benefits. A multidisciplinary approach with early surgeon involvement is crucial for optimal orthopedic care.
Area of Science:
- Oncology
- Orthopedic Surgery
- Pharmacology
Context:
- Metastatic bone disease management is evolving.
- Bone modifying agents (e.g., bisphosphonates, denosumab) reduce skeletal events.
- Novel anticancer drugs, including molecular-targeted therapies, improve bone metastasis prognoses.
Purpose:
- To highlight the impact of recent therapeutic advances on surgical indications for bone metastases.
- To emphasize the need for a multidisciplinary approach in managing patients with bone metastases.
Summary:
- Drug therapy advancements are shifting the landscape for surgical interventions in metastatic bone disease.
- Improved prognoses due to novel drugs may expand eligibility for surgical benefits.
- Orthopedic treatments like bracing, rehabilitation, and surgery (local tumor control, palliative fixation, spinal decompression) require early surgical consultation.
Impact:
- Enhanced patient outcomes through integrated drug and surgical therapies.
- Optimized treatment strategies for bone metastases.
- Increased potential for patients to benefit from surgical interventions.
Related Concept Videos
01:27Fractures: Bone Repair
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
01:28Urinary Tract Calculi V: Nursing Management
01:31Osteoclasts in Bone Remodeling
01:30Urinary Tract Calculi III: Medical Management